Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 350 of 6351
-
Magic mushroom therapy targets inherited trauma
Symptom relief Recruiting nowThis is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therap…
Phase 2 • Sponsor: Rachel Yehuda • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
Leukemia combo shot and pill shows promise in early trial
Disease control Not yet recruitingTo find out if giving blinatumomab as injections under the skin and olverembatinib can help to control the disease in patients with Ph-positive ALL.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New trial hunts down lingering melanoma DNA to stop cancer return
Disease control Recruiting nowClear-Me is a biomarker-driven phase II study that tests whether the combination anti- lymphocyte-activation gene-3 (LAG3)/anti-programmed cell death protein 1(PD-1) inhibition Bristol-Myers Squibb (BMS986213) is superior to anti-PD-1 inhibition in patients with detectable circul…
Phase 2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Could a common steroid save lives in severe lung failure?
Disease control Recruiting nowAcute respiratory distress syndrome (ARDS) is a major cause of acute hypoxemic respiratory failure in critically ill patients and is associated with substantial mortality. Current management is largely supportive, and no pharmacologic therapy has been shown consistently to reduce…
Phase 3 • Sponsor: Southeast University, China • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New shot aims to tame hepatitis b without daily pills
Disease control Recruiting nowThis study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with CHB treated with Nucleos(t)ide Analogue (NAs).
Phase 2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Buoyancy vs. gravity: which exercise wins for lipedema relief?
Symptom relief Not yet recruitingTo evaluate optimal workout environments, a 12-week study assigned women with moderate-to-severe lipedema to three distinct protocols: supervised pool workouts, equivalent land-based training, or basic standard monitoring. Researchers tracked walking endurance alongside tissue co…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can a 5-Week talk program break the isolation of diabetic foot ulcers?
Symptom relief Not yet recruitingThe goal of this interventional study is to develop and preliminarily evaluate a solution-focused model-based intervention program for reducing social isolation in elderly patients with diabetic foot ulcers. It will also learn about the feasibility and safety of the intervention …
Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
A quest to find biomarkers that match melanoma patients with the right immunotherapy
Knowledge-focused Not yet recruitingCutaneous melanoma is an aggressive malignancy with a rising global incidence; its prognosis has been radically transformed by immune checkpoint inhibitors (ICIs), a class of immunotherapeutic agents targeting immune regulatory pathways such as programmed cell death protein 1 (PD…
Sponsor: European Institute of Oncology • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Can blocking knee blood vessels ease arthritis pain without surgery?
Symptom relief Recruiting nowTo explore associations with demographics/clinical factors; assess trajectories via annual follow-up; evaluate healthcare utilization and barriers; oversample \>10-year survivors.
Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can probiotic spores tame Crohn's and colitis Flare-Ups?
Disease control Not yet recruitingInflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a chronic relapsing intestinal disorder driven by immune dysregulation, impaired mucosal barrier function, and gut microbiome dysbiosis. Although current therapies can control inflammation, man…
Sponsor: Anabio R&D • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New drug trial aims to protect Kids' kidneys from IgA nephropathy
Disease control Recruiting nowA Phase III, single-arm, multicenter pediatric clinical study evaluating atrasentan in children and adolescents aged 2 to \<18 years with primary immunoglobulin A nephropathy (IgAN).
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can a lab technique mature eggs more gently for IVF?
Disease control By invitation onlyA study to assess the Capacitation - in-vitro maturation (CAPA-IVM) system as an option for patients with a good ovarian reserve to achieve pregnancy.
Sponsor: Inception Fertility Research Institute, LLC • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
MRI-Guided prostate cancer treatment cuts radiation to just 2 doses
Disease control Recruiting nowA number of recent studies have successfully reduced the number of radiotherapy treatments used for prostate cancer from 39 daily treatments to as little as 5 treatments. This study is designed to determine how tumors inside the prostate respond during these 5 treatments on magne…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could exercising in thin air melt belly fat faster?
Disease control Recruiting nowOverweight and obesity are major public health challenges worldwide, and their prevalence increases with age, partly because of age-related metabolic and hormonal changes. Beyond total fat mass, abdominal and particularly visceral fat accumulation is strongly associated with chro…
Sponsor: Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a new injection help shed excess weight?
Disease control Not yet recruitingThis study is a multicenter, randomized, double-blind, placebo-controlled, single and multiple ascending-dose phase 1 clinical trial aimed at evaluating the safety, tolerability, PK, PD, and immunogenicity of MWN110 Injection in healthy participants and overweight or obese partic…
Phase 1 • Sponsor: Shanghai Minwei Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New hope for tough myeloma: Two-Drug combo takes on relapsed cancer
Disease control Not yet recruitingThis phase II trial compares the effect of the combination of daratumumab-hyaluronidase (daratumumab) and teclistamab to the usual treatment of daratumumab, pomalidomide, dexamethasone or daratumumab, carfilzomib and dexamethasone in treating patients with multiple myeloma that h…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a simple test spot oral cancer and gum disease early?
Knowledge-focused Not yet recruitingThe goal of this observational study is to develop better ways to detect and predict major oral diseases, including oral cancer, gum disease, and tooth decay. This study will collect detailed oral health information and biological samples from adults with different oral health co…
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Can a Long-Term watch program unlock the secrets of genetic prion disease?
Knowledge-focused Recruiting nowPROSPECT is a prospective observational registry and longitudinal natural history study of adults at risk for genetic prion disease.
Sponsor: Brian Appleby • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can neck exercises turn down the volume on chronic migraine?
Symptom relief Not yet recruitingTo investigate the effectiveness of mechanism-based cervical sensorimotor rehabilitation on cervical muscle activation, cervical proprioception, and migraine burden.
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Kidney transplants: a smarter way to dose Anti-Infectives?
Knowledge-focused Not yet recruitingThis study addresses the clinical problem that reliance on serum creatinine, eGFR or empirical dosing fails to accurately adjust anti-infective doses given rapid renal function shifts within the very early 0-5 days post kidney transplantation. We will systematically analyze dynam…
Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC